TX-MARY-KAY
21.11.2023 18:04:33 CET | Business Wire | Press release
Mary Kay Inc., a global beauty brand and advocate for women’s empowerment, is excited to announce its membership in the Global Shea Alliance (GSA), a non-profit industry association that designs, develops and delivers strategies that drive a competitive and sustainable shea industry worldwide. This new partnership aligns with Mary Kay's commitment to sustainability and its mission to empower women around the world.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231121605161/en/
“This partnership marks a significant step in our journey to promote sustainable beauty practices. By collaborating with the Global Shea Alliance, we aim to further harness the transformative potential of shea in skincare and cosmetics," said Deborah Gibbins, Chief Operating Officer at Mary Kay. (Credit: Mary Kay Inc.).
The GSA's core values are founded on promoting an inclusive value chain, fostering a pre-competitive and business-driven industry by ensuring sustainability and maintaining confidentiality in all transactions with its stakeholders.
“We are absolutely thrilled to join the Global Shea Alliance,” said Deborah Gibbins, Chief Operating Officer at Mary Kay. “This partnership marks a significant step in our journey to promote sustainable beauty practices. By collaborating with the GSA, we aim to further harness the transformative potential of shea in skincare and cosmetics.”
Mamatou Djaffo, President of the Global Shea Alliance, expressed her enthusiasm about the new partnership. “We extend a heartfelt welcome to Mary Kay Inc,” said Mamatou Djaffo. “Their stellar reputation as champions of corporate social responsibility and sustainability perfectly aligns with our mission. We are thrilled at the prospect of collaborating with Mary Kay to drive substantial positive change within the cosmetics industry. Together, we aim to establish new industry standards for social and environmental responsibility, transcending beauty to empower individuals, promote sustainability, and foster a more resilient future for the millions of women who depend on shea.”
This exciting partnership between Mary Kay Inc. and the Global Shea Alliance in the upcoming year will spearhead initiatives aimed at enhancing the economic well-being of shea collectors and processors, as well as undertaking crucial efforts to restore degraded parklands in West Africa.
Earlier this month, Mary Kay hosted Aaron Adu, GSA Managing Director, and Olawunmi Osholake, GSA Deputy Managing Director, at its manufacturing facility, the Richard R. Rogers (R3) Manufacturing / R&D Center in Lewisville, Texas, U.S.A. for a site visit followed by a meeting exploring synergies and engagement opportunities.
About Mary Kay
Then. Now. Always. One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty brand in Texas in 1963 with one goal: to enrich women’s lives. That dream has blossomed into a global company with millions of independent sales force members in more than 35 countries. For 60 years, the Mary Kay opportunity has empowered women to define their own futures through education, mentorship, advocacy, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in preserving our planet for future generations, protecting women impacted by cancer and domestic abuse and encouraging youth to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram and LinkedIn, or follow us on X (formerly known as Twitter).
About Global Shea Alliance
The GSA is a non-profit industry association with 919 members from 39 countries including women collectors and processors, brands and retailers, ingredient suppliers, civil society, research institutions and policymakers. Through public-private partnerships, the GSA promotes industry sustainability, quality practices and standards and demand for shea in food and cosmetics. For more information, please visit https://globalshea.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231121605161/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Okomera Strengthens Its Leadership Team With the Appointment of Marion Ghibaudo as Chief Technology Officer16.9.2026 08:00:00 CEST | Press release
An expert in scaling medical innovations, Marion Ghibaudo joins Okomera as the company advances toward industrial deployment. Okomera, a TechBio company pioneering next-generation cancer care through the development of a proprietary technology platform combining tumor mini-avatars, microfluidics, and AI-powered imaging, today announced the appointment of Marion Ghibaudo as Chief Technology Officer. She will spearhead the company’s technology and innovation strategy and lead the industrial deployment of its integrated hardware, software, and biological platform. Marion Ghibaudo will join Okomera’s Executive Committee and report to CEO Silvère Lucquin. In parallel, Raphaël Tomasi, Okomera’s co-founder and former CTO, transitions to the role of VP Platform, ensuring continuity in the development of the company’s technology platform. Marion’s appointment comes at a key stage in Okomera’s growth as the company advances toward pilot studies, industrial scale-up, and commercialization. Okomer
Galderma’s Restylane® Volyme™ Demonstrates High Effectiveness, Satisfaction and a Robust Safety Profile in Chinese Patients With Temple Hollowing16.9.2026 07:00:00 CEST | Press release
Positive topline results showed that Restylane Volyme (known as Restylane Contour in the U.S.) was highly effective in the correction of moderate-to-severe temple hollowing, with high responder rates maintained through Month 121 Restylane Volyme was well tolerated, with no incidences of granulomas. Patient and investigator satisfaction were also high1 These data support Galderma’s aim to expand the availability of the Restylane portfolio in China – a market undergoing significant expansion, and further strengthen Restylane’s vast clinical evidence base2,3 Galderma (SIX: GALD) today announced positive topline results from a study of Restylane Volyme for the correction of moderate-to-severe temple hollowing in 162 patients in China.1 The study met its primary endpoint, demonstrating the effectiveness and safety of Restylane Volyme versus a no-treatment control, while also achieving high patient and investigator satisfaction.1 These data further reinforce Galderma's ambition to expand its
Nippon Electric Glass’s IR Transmitting Glass “FI-02” Adopted for Heimann Sensor Lens Unit, Enabling a 120° × 68° Field of View16.9.2026 03:00:00 CEST | Press release
Nippon Electric Glass Co., Ltd. (NEG) (TOKYO: 5214), a global leader in specialty glass headquartered in Otsu, Japan, announced that its IR Transmitting Glass (chalcogenide glass) “FI-02” has been adopted for Heimann Sensor GmbH’s wide-angle lens unit for thermal cameras. The lens unit achieves a 120° × 68° field of view, surpassing the previous product’s maximum of 92° × 59°. The adoption marks a significant milestone for FI-02 and showcases how advanced specialty glass can meet the demanding optical and manufacturing requirements of the expanding infrared sensing market. Thermal cameras detect infrared radiation emitted by people or objects and convert it into thermal images. Infrared sensors can detect the locations of people and temperature distributions. They are expected to be used for people detection and monitoring, where privacy considerations are important, and for air-conditioning control, while their use is expanding in healthcare, equipment monitoring, and security. Advanc
Workiva Advances Regulatory Work with AI Innovation15.9.2026 17:00:00 CEST | Press release
Agent Studio anchors AI capabilities unveiled at Amplify 2026 Workiva Inc. (NYSE: WK), a leading, audit-ready platform for trust, transparency, and accountability, unveiled dozens of new product and platform innovations at Amplify 2026, the company’s annual conference attended by thousands of finance, accounting, sustainability, risk, and compliance leaders. Workiva Debuts Agent Studio Workiva introduced Agent Studio, a landmark platform capability that empowers users to quickly build, customize, and deploy AI agents in Workiva's trusted platform. By combining AI reasoning with Workiva's native platform capabilities, enterprise knowledge, and governed workflows, Agent Studio enables users to automate sophisticated manual business processes without writing any code. Organizations can enrich agents with company-specific knowledge and context, tailor them to their own processes, and schedule automations to execute recurring work. “With Agent Studio, we're putting the power to build in the
Study: Heatwaves Increase Cough Urge, Which Salt Aerosols Reduce15.9.2026 15:15:00 CEST | Press release
New Study Indicates Non-Pharmacological Aerosol May Provide Therapeutic Relief for Respiratory Conditions Provoked by the Atmospheric Aridity Inherent to Heatwaves SC Therapeutics, with University North Carolina, Imperial College London, and Boston University, announced publication on Tuesday in Nature Scientific Reports of results from a multi-institutional study indicating that the aridity inherent in heatwaves increases cough hypersensitivity in human airways by collapsing mucus onto cilia in a manner common to chronic respiratory diseases, such as cystic fibrosis, and asthma. The researchers find that alkaline aerosols of magnesium salts reverse mucosal collapse for several hours, and reduce cough hypersensitivity as reflected in placebo-adjusted suppression of daily cough bout rate (59%, p=0.03) and persistence of suppression post treatment for 1 to 3 weeks in a randomized, double-blind, placebo-controlled study of 10 refractory chronic cough patients. “Paris recorded 5,764 excess
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom